Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Feb 18, 2021 12:36pm
67 Views
Post# 32596600

RE:Potential CB Product

RE:Potential CB ProductI sold too, yesterday, took small green as my entry was very low from last year. I will keep an eye on this and will position again in opportune time. Got my eye on P-esbp, I really like that one. But I got to take my gain though small and have to make money somewhere first. I will see you again VXL and will keep you on my watchlist.  VXL mgt please make sure you make Dr. Ayelet David happy, I have my eye on that P-esbp application.


Cherrypink wrote:
Sponsored Post:
 
These other companies might also be well exposed to the psychedelic medicine market, which Eight Capital claims could be worth around $100 billion. This might get you interested! Check this out!

It was said that US FDA appears to be supportive of psilocybin research. In 2018, for example, the agency recognized psilocybin as a potential “breakthrough therapy” for depression.
 
These other companies clinical studies from prestigious institutions such as Johns Hopkins Medicine, and New York University appear to already be showing positive results. Check disclaimer on landing page and in my profile.



<< Previous
Bullboard Posts
Next >>